GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (LTS:0DPB) » Definitions » Sale Of Investment

Bavarian Nordic AS (LTS:0DPB) Sale Of Investment : kr1,295 Mil (TTM As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Bavarian Nordic AS Sale Of Investment?

Bavarian Nordic AS's sale of investment for the three months ended in Dec. 2024 was kr723 Mil. It means Bavarian Nordic AS gained kr723 Mil from selling investments. Bavarian Nordic AS's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was kr1,295 Mil.

Compared with last quarter (kr555 Mil in Sep. 2024 ), Bavarian Nordic AS gained more money from selling investments in Dec. 2024 (kr723 Mil).


Bavarian Nordic AS Sale Of Investment Historical Data

The historical data trend for Bavarian Nordic AS's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Sale Of Investment Chart

Bavarian Nordic AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,141.68 336.34 1,088.24 1,912.95 1,294.99

Bavarian Nordic AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.69 5.63 11.33 554.60 723.43

Bavarian Nordic AS Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,295 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bavarian Nordic AS Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic AS's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic AS Business Description

Address
Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines

No Headlines